Citadel Advisors
IDIX

Citadel Advisors’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Citadel Advisors’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-43,800
Closed -$1.06M – 8800
2014
Q2 		$1.06M Buy
43,800
+8,500
+24% +$88.6K ﹤0.01% 3423
2014
Q1 		$213K Buy
35,300
+11,000
+45% +$76.7K ﹤0.01% 5454
2013
Q4 		$145K Sell
24,300
-1,900
-7% -$8.79K ﹤0.01% 5315
2013
Q3 		$137K Buy
26,200
+13,500
+106% +$59.2K ﹤0.01% 5107
2013
Q2 		$46K Buy
+12,700
New +$51.9K ﹤0.01% 5713

Citadel Advisors's IDIX Position: Q3 2014 in Review

Citadel Advisors sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 14,069 shares — an estimated $339K sold.

Citadel Advisors first reported a position in IDIX in Q2 2013 and held it in 4 quarters. The position peaked at $6.55M in Q1 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Citadel Advisors reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Citadel Advisors sold 14,069 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $339K.
  • Citadel Advisors first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 4 quarters.
  • Citadel Advisors's IDENIX PHARMACEUTICALS INC position peaked at $6.55M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Citadel Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.